Kriba is joining the Spanish Society of Nephrology 2024 annual congress as an exhibitor in the commercial exhibit. Held in Valencia, Spain from Friday, November 8 to Sunday, November 10, 2024 it is the 54th annual gathering of leading Spanish nephrology professionals. It is an opportunity to showcase our latest advancements, clinical trial results and to engage with Spain’s nephrology community, deepening our understanding of the unique needs of specialists in this field.
The annual congress has a comprehensive program featuring a range of sessions and various symposia, technical forums, and presentations focused on current research and clinical practices, making it a prime opportunity for networking and knowledge exchange among Spanish nephrology specialists. The commercial exhibition highlights innovations in renal care and dialysis, aligning with the themes of the congress.
This onsite presence allows us to support and grow alongside nephrology professionals. Our involvement builds on our recent exhibitions at the Spanish National Reunion of Home Peritoneal and Home Hemodialysis (Pamplona, Spain), ASN Kidney Week (San Diego, CA), and the ISPD Congress (Dubai), each vital in advancing early detection and prevention of PD-Associated peritonitis through expert collaboration.
We are also looking forward to share results and insights gathered in our multicenter clinical study in collaboration with Hospital Universitari de Bellvitge, Hospital Clínic de Barcelona, Complejo Hospitalario de Navarra, Hospital del Mar, Consorci Sanitari de Terrassa and Hospital Sant Joan Despí Moisés Broggi.
At Kriba, we’re advancing non-invasive early detection and prevention of infections in extravascular fluids—including PD-associated peritonitis, infant meningitis, uveitis, and more— improving outcomes across diverse clinical settings worldwide.
Our aim to advance early detection and prevention of PD-associated peritonitis complications. That’s why we are developing Neosonics© Vitro Kidney, a device that non-invasively determines white blood cell increases and differential directly on PD drainage bags. If you are curious to see it in action, stop by our information stand M3 and to try it out.
The Kriba team is progressing toward obtaining CE mark certification by late 2025 and FDA approval in 2026.
Neosonics© Vitro Kidney is currently under development and is not available for sale. It has not been approved by the FDA and received CE marking.
